SCHERING-PLOUGH PHARMACEUTICAL PRESIDENT CONKLIN TO HEAD OTC GROUP

SCHERING-PLOUGH PHARMACEUTICAL PRESIDENT CONKLIN TO HEAD OTC GROUP under a top-level management reshuffling announced July 7. Effective Sept. 1, Schering-Plough Exec VP Donald Conklin, 57, who has directed the company's worldwide prescription drug business since 1986, will become president of Schering-Plough HealthCare, replacing David Collins. Schering-Plough HealthCare's brands include Coppertone, Shade and Tropical Blend sunscreens and Dr. Scholl's foot care products.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from HBW Insight

Moberg Nail Fungus Line Takes Lead In Norway As Firm Plots EU Expansion

 
• By 

Terclara - Moberg’s proprietary topical formulation of terbinafine for fungal nail - has established itself as the market leader in Norway just months after its OTC launch. The firm is now plotting its expansion to additional EU markets.

PAGB: UK Gov Must Invest In Self-Care To Realize ‘Untapped Potential’

 
• By 

Reacting to chancellor Rachel Reeves' 2025 public spending review, PAGB welcomed increased funding for healthcare and life sciences while stressing the need to promote self-care practices.

Summer Beauty: Scalp, Hair Growth Ranges, Lip Balms Under Beauty/Food Deals

 

Arbonne International’s Hair Care Collection Scalp Elixir demonstrated improvement in scalp buildup in 96% of participants in a small study. Separately, It’s a 10 Haircare has extended with a new range, F.A.S.T. Haircare, clinically proven to grow hair up to 99% faster; Beauty Launch Roundup